Lymphoma is the most common cancer in cats. Understanding the welfare dimensions of diagnosis, treatment and the decision-making process helps owners navigate this difficult journey.
Feline lymphoma welfare management is similar to canine cancer welfare in its core principle: quality of life is the primary measure, not length of life. The distinction between low-grade and high-grade lymphoma is crucial for welfare-informed decision making - low-grade GI lymphoma in cats is one of the most treatment-responsive cancers in veterinary medicine, with most treated cats maintaining good quality of life for years. High-grade lymphoma is more challenging and decisions about treatment intensity must weigh the cat's tolerance of treatment against uncertain outcomes. Cats are often stoic and owners may underestimate the welfare cost of advanced disease - regular quality of life scoring with veterinary guidance enables timely, welfare-centred decisions.